Related Experiment Video
Updated: May 9, 2026
08:44
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
Published on: August 21, 2020
Hemolysis testing in circulatory support pumps: Standards, mock loops, and pulsatility
Sung-Min Park1, Seong-Wook Choi2
1Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Chuncheon-si, Gangwon, Republic of Korea.
The International Journal of Artificial Organs
|May 7, 2026
Summary
Current in vitro hemolysis testing for blood pumps fails to capture pulsatile flow, leading to inaccurate safety assessments. New methods are needed to better mimic clinical conditions for reliable blood pump evaluation.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Hemodynamics
Background:
- Hemolysis evaluation is critical for blood pump safety in extracorporeal support.
- Existing standardized in vitro tests do not fully represent clinical pulsatile and transient hemodynamic conditions.
- Clinically relevant hemolysis persists despite current testing protocols.
Purpose of the Study:
- To review and synthesize recent literature on in vitro hemolysis testing methods.
- To emphasize pulsatility-aware evaluation frameworks for blood pumps.
- To identify limitations of conventional testing and highlight emerging approaches.
Main Methods:
- Narrative, methods-focused review of in vitro hemolysis testing literature.
- Analysis of limitations in large-volume loop testing.
- Summary of emerging techniques: reduced-volume paired-loop testing, hybrid mock circulatory loops (HMCL).
- Identification of quantitative descriptors for pulsatility and minimum reporting requirements.
Main Results:
- Conventional steady or quasi-steady test protocols inadequately represent pulsatile flow in devices like LVAD and VA-ECMO.
- Emerging methods like HMCL can reproduce heart-pump interactions.
- Standardized reporting of operating and blood-handling descriptors is crucial for reproducibility.
Conclusions:
- In vitro hemolysis evaluation frameworks must better reflect clinical pulsatile operating conditions.
- Pulsatility-aware testing is essential for accurate benchmarking of blood pumps.
- Improved testing will facilitate objective comparison of pulsatile blood-pump technologies.
